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Abstract
Relations among hormone serum concentrations are complex and depend on various factors, including gender, age, body
mass index, diurnal rhythms and secretion stochastics. Therefore, endocrine deviations from healthy homeostasis are not
easily detected or understood. A generic method is presented for detecting regulatory relations between hormones. This is
demonstrated with a cohort of obese women, who underwent blood sampling at 10 minute intervals for 24-hours. The
cohort was treated with bromocriptine in an attempt to clarify how hormone relations change by treatment. The detected
regulatory relations are summarized in a network graph and treatment-induced changes in the relations are determined.
The proposed method identifies many relations, including well-known ones. Ultimately, the method provides ways to
improve the description and understanding of normal hormonal relations and deviations caused by disease or treatment.
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Introduction
Serum hormone concentrations vary considerably, both be-
tween subjects and within subjects, between days and during the
24-h day-night cycle. The variation in serum concentration is the
result of secretion from endocrine glands into the circulation and
clearance from the blood [1]. Secretion consists of basal
(nonpulsatile) and pulsatile (burstlike) secretion. The serum
concentration profile is hormone-specific [1,2]. It is increasingly
recognized that the pulsatile hormone secretion process supports
important biological functions and that a more constant blood
hormone concentration tends to diminish the sensitivity of the
target tissues to that particular hormone [3].
The awareness of the variability in hormone concentrations
emerged in the 1960’s with the introduction of radioimmunoas-
says. The appreciation of within-day variability is still not
implemented in the current clinical evaluation of a patient’s
endocrine status, except the diagnosis of Cushing’s disease [4].
Generally, patients are tested at a single time point in the morning
under fasting conditions. Such diagnostic tests ignore the
variability and important pulsatile features of circulating hormone
concentrations. In rare cases patients are tested at one or few time
points after experimental perturbation (for example, the oral
glucose tolerance test [5], or the GHRH-arginine stimulation test
[6]).
Hormone secretion is regulated by other hormones; their
dynamic interrelations modulate critical functions in target tissues.
For example, insulin increases the glucose uptake by the liver and
muscle [7]. On the other hand, hormone secretion is often
influenced by several other factors, including gender, body
composition, age, and other hormones [8,9].
The regulation of pituitary hormone secretion is controlled by
hypothalamic hormones, delivered via the pituitary portal system
and feedback signals from the periphery acting on the different
pituitary cell types and/or hypothalamic nuclei, synthesizing and
secreting pituitary-stimulating or inhibiting neurohormones or
transmitters. Feedback signals include hormones synthesized by
endocrine glands, for example, estrogens, testosterone, thyroid
hormones, cortisol, and IGF-I, and metabolic signals, including
leptin and insulin. The knowledge of the complex central
processing of the feedback signals (either positive or negative) is
largely based on physiological studies performed in animals. While
other information about the human signalling is derived from
studies in patients with activating or muting gene deletions, or by
clamping studies in which one or more signals are fixed [10–13]).
One way to characterize the regulatory relations is to construct
networks of these interrelations. Network representations of
dynamic patterns can be obtained by models like dynamic
Bayesian networks or Hidden Markov Models (HMM) [14–16].
In HMM, networks can be built from time-delayed associations.
The applicability of HMM for detecting the interrelation between
hormones is limited for at least two reasons. First, many hormone
interdependencies are reciprocal and are best represented by a
cyclical graph, which has to be accounted for in the more complex
Hierarchical Hidden Markov Models. In addition, the interrela-
tion delays cannot be assumed to be equal among all hormone
relations, which prohibits the use of (first order) HMM. Although
higher order Markov Models do allow for unequal delays, many
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additional parameters need to be estimated which makes the
model complex and more difficult to interpret. Hence, the existing
HMM methods are too rigid for application to hormonal systems.
Therefore, a new strategy with less rigid assumptions was adopted.
The proposed network inference methodology is capable of
handling some types of reciprocity and unequal delays.
The methodology is illustrated with a case study in obese but
non-diabetic women. The detected relations between circulating
hormones before and after treatment are analyzed and visualized
in a network. Relating secretion patterns of circulating hormones
attempts to unravel known and unknown relations between
hormone systems. The latter is without pretending that any
unknown relation, if statistically significant, is proof of a direct
relation. However, such (unexpected) relations may motivate
further investigations in human or animal models to describe
detailed mechanistic dependencies. The study used to illustrate this
methodology investigated the acute effects of bromocriptine on
leptin levels, while keeping caloric intake constant. Leptin is the
satiety hormone that signals the volume of adipose store to the
brain. Bromocriptine is reported to lower the plasma leptin
concentration in subjects with prolactinoma, without affecting
body weight [17]. Because of the implicated metabolic processes,
prolactin, GH, TSH, glucose and insulin are also measured, as are
the HPA hormones ACTH and cortisol.
Materials and Methods
2.1 Experimental data
The data that is used to illustrate the network inference method
comes from a clinical study involving a premenopausal cohort
(n = 18) of obese individuals (BMI.30 kg/m2) with mild insulin
resistance [17–19]. The average height of the subjects was 1.68 cm
(range 1.55–1.76), with a SEM of 1.2 cm. The average weight of
the subjects was 94.4 kg (range 83.7–118.1), with a SEM of 2.51 kg.
The ethical board of Leiden University Medical Center
evaluated and approved the (original) study. All subjects provided
their written consent. The subjects were recruited through
advertisements in local newspapers [17]. Exclusion criteria were
acute or chronic disease, depression, head trauma, smoking,
alcohol abuse, recent transmeridian flights, nightshift work, and
recent blood donation. All participants were required to have
regular menstrual cycles, the studies were done in the early
follicular phase of the menstrual cycle [17]. A total of 246 ml of
blood was collected during each occasion. The subjects were
instructed to remain recumbent, except for bathroom visits. The
subjects were provided with a standardized liquid breakfast (0930),
lunch (1300), and dinner (1830). The caloric content was fixed at
2100 kcal/d, of which 35% came from fat, 49% from carbohy-
drates and 16% from proteins [17]. The lights were switched off at
2300, and back on at 0730.
Blood samples were collected every 10 minutes for 24 hours to
assess the endocrine state of the women. The samples were drawn
from the antecubital vein, in which a canula and a stopcock was
kept patent by continuous NaCl and heparin infusion [17]. In each
sample the concentration of ACTH, cortisol, GH, TSH, prolactin,
leptin, insulin, and glucose was determined. This list is referred to
as the hormones, even though it is noted that glucose is not a
hormone, this convention is for brevity only. The subjects were
subsequently treated with two daily doses of 2.5 mg bromocriptine
during 8 days. On the last day of the treatment the subjects
underwent again a 24-h blood sampling study. Figure 1 shows the
24-h hormone concentration profiles in a representative subject.
2.2 Methods
A network representation offers a comprehensive view of the
dynamic relations that exist between hormones. The network
summarizes the complex regulatory patterns into interpretable
Figure 1. Twenty four-hour hormone concentration profiles in a representative healthy obese female subject who was treated with
bromocriptine for eight days. The black lines show the concentrations before treatment, the gray lines after treatment. Bromocriptine caused a
profound decrease in prolactin levels, and a decrease in serum TSH, ACTH and leptin concentrations, while increasing GH levels. In addition, insulin
and glucose levels also were deminished by bromocriptine.
doi:10.1371/journal.pone.0096284.g001
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descriptions. The network inference strategy uses estimated
secretion rates to assess the association between hormones.
2.2.1 Pulse identification. The estimation of secretion
pulses from observational data is not trivial. The secretion and
decay are difficult to delineate and the translation to mathematical
formulae of these mechanisms does not yield a well-posed
problem. A constraint based method with a minimal set of
assumptions was used to estimate the mass and timing of secretion
pulses [1]. Recently two other operator-independent deconvolu-
tion programs for simultaneously estimating hormone pulses,
secretory mass and hormone half-lives were described (AutoDecon
[20] and an algorithm by Keenan et al [21,22]) but here we use
our own method (VisPulse [1]). As the overlap between
AutoDecon and VisPulse estimates is considerable [1], highly
similar results are to be expected when one of the other methods
was to be used.
The use of secretion profiles, assessed by pulse identification
methods, was motivated by the desire to reduce the auto-
correlation present in the original concentration profiles, see also
Vis et al [23]. Such auto-correlation distorts many types of
measures, including cross correlation. Besides reducing the auto-
correlation, the use of secretion profiles also focuses the analysis to
the hormone release into the serum compartment.
2.2.2 Hormone association. As a measure of the association
between two hormones the lagged Pearson product moment
correlation (that is, cross correlation) is used on the secretion
pulses. It is assumed that the lag of highest positive and/or lowest
negative (optimal) cross-correlation between two hormones
represents the time domain in which regulation between two
hormones is effectuated. This characteristic is used to create a
network representation; if a significant optimal cross-correlation
exists, it is stated that there is a relationship between hormones.
The unit of the lag is the time interval between two sampling
points, 10 minutes, and is referred to by the Greek letter t.
2.3 Network inference
2.3.1 Inference of a static network. A static or instanta-
neous network is based on links between hormones that are
present without a time lag. This is the commonest application of
association networks found in the literature. The reason for that is
largely based on the lack of time series data. The associations are
usually made with a number of subjects presumed to be in a
steady-state. Since this is a time series of a set of subjects time lags
can be included. As a reference, also a static network analysis is
performed.
A static network is constructed by associating the pulse pattern
of one hormone with the pulse pattern of another. The links of a
network are included when the resultant association is significant.
The association values are calculated per subject, these values are
deemed significant when they are similar across the set of subjects,
as assessed by a t-test. A false discovery rate correction is applied
and a threshold of 5% is used.
A large body of research discusses the merits of conditioning on
other variables to limit the detection of indirect relations. The
procedure is better known as partialization, the variation of other
variables is regressed out of the variable pair of interest before
calculating the association in the first pair. This procedure is
widely used in graphical Gaussian network modeling [24,25]. We
applied such partialization on the static network by calculating the
partial correlation for each pair per subject (for details: see the
Appendix). The partial network is included to let the reader
inspect the relative gain in interpretability achieved with this
procedure for this data. The correlation and partial correlation
networks are given in the Results section.
2.3.2 Dynamic network inference. Some relations between
two hormones are characterized by a delay between them. The
dynamic network appreciates such a delay, while the static
network does not. The relation between the hormones is
characterized by the cross-correlation. The optima, or extremes,
Figure 2. Twentyfour-hour cortisol concentration profile in a healthy obese woman. The secretion amplitude and timing were estimated
by VisPulse which is a mathematical model with minimal assumptions, only an exponential decay is assumed and the secretion is assumed to be
episodic. The latter is interpreted to mean that only a limited set of time points are involved in the episodic secretion, no assumptions are made
about the distribution of the secretion. The residuals are without significant autocorrelation.
doi:10.1371/journal.pone.0096284.g002
Network Identification of Hormonal Regulation
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e96284
in the cross-correlation function define the delay. To allow for
both positive and negative delayed relations, two optima are
defined for each pair of hormones. The time window in which
regulatory relations are considered is four hours. The mathemat-
ical details of the inference can be found in the Appendix.
After calculating the optima, three validation steps are included.
First, to test the robustness of the found optima a resampling
strategy was followed. This is performed by repeatedly leaving out
two subjects and redoing the analysis. The modes of all the
calculated cross-correlation functions are then examined to assess
the robustness (see Appendix). Secondly, the significance of the
cross-correlation value at the optimal delay is assessed by testing
the average cross-correlation at the optimum against the
assumption that there is no relation, that is, the association is
zero. The test is one sided because the optimum is either positive
or negative. The resulting p-values are subjected to a false
discovery rate (FDR) correction at the a = 0.01 level. The explicit
optimization of searching for the optimal delay is compensated for
by adopting a more conservative threshold. Note that this sort of
optimization is not used in the static network inference, nor the
evaluation of the treatment effect (see later). Thirdly, it is assessed
whether the optimal delay is different from zero by using the
between individual variation of the cohort. In case of a significant
difference there is evidence (but not proof) of a causal relation
between the two hormones, which is shown as an arrow in the
network. The delayed relations are reported such that when b
follows a the network shows an arrow between the two, for
example, aRb. More details about the mathematics involved in
these procedures is shown in the Appendix.
The rationale for setting up this analysis is to detect changes in
the regulatory relations between hormones. Treatments or
different phenotypic states can influence the relation between
two hormones. Changes in the regulatory relation between two
hormones can be twofold; their delay can change and/or the
intensity of the regulation at a specific delay can change. In this
paper we select a reference situation with a specific (optimal) delay
calculated for this situation. All other situations are then compared
to the reference situation in terms of intensity of the regulation at
the pre-selected reference delay. This captures both facets of
change: i) if the optimum delay shifts in the new situation, then the
intensity at the (then non-optimal) pre-selected delay tends to
diminish and ii) if the optimal delay remains the same but the
tightness of the regulations changes, then this will manifest itself as
an intensity change.
In the preceding section on static network inference the idea of
partialization was introduced. In a dynamic network partialization
also has relevance, but it is not clear how to perform this. Whereas
in the static network the partial correlation of two hormones has to
be established while correcting for all other six hormones, this
number of partializing variables explodes when considering time
delays. How many delays should be included the partialization
step? Obviously, such an explosion of possibilities leaves room for
chance results. Methods to validate the resulting partial correla-
tions are far from trivial. Hence, we restrict ourselves to
correlations instead of partial correlations for the dynamic nets.
Moreover, use of hormone secretion values lowers the risk of
finding indirect correlations considerably.
2.3.3 Treatment effect. The study used two sampling series
of subjects, one before and one after a treatment with bromo-
criptine. To assess whether the treatment did change the
amplitude in the network, the before treatment and after
treatment cross correlation values were evaluated using a paired
t-test (see Equation 11). The treatment effect is assessed and
subjected to an FDR correction. Effects are deemed significant,
after FDR correction, at a = 0.05, additionally, the relations with a
tendency (0.05,a,0.10) to a treatment effect are also reported.
Results
3.1 Pulse identification
Pulsatility is a characteristic of the secretion process of many
hormones. An attempt is made to estimate the timing and
amplitudes of the secretion pulses with a previously developed
Figure 3. Correlation A and partial correlation B hormone networks. The significant links show a high degree of overlap between the
correlation and the partial correlation networks.
doi:10.1371/journal.pone.0096284.g003
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numerical method (VisPulse [1]). Figure 2 shows a typical example
of a 24-hr hormone series, here an example of cortisol, that was
modeled with VisPulse. In gray the measured data is shown and in
black the modeled data. The concentration profile shows a clear
diurnal pattern with a nadir in the afternoon and evening, and a
zenith in the early morning, which is the normal pattern for
cortisol. The model correctly identifies the concentration spikes, or
pulses, that are characteristic for the 24-hr levels of many
hormones, including cortisol. The estimated secretion gives insight
in the timing and the mass of the pulses of cortisol released to the
general circulation. The data and the minimal model assumptions
are well matched as both are in concordance. As discussed in the
Method section, all following analyses will be performed on the
estimated secretion profile.
3.2 Static network inference
The static association network is created by calculating for each
subject the correlation between all hormone pairs. For each
hormone pair the estimated correlation for all subjects is tested for
being unequal to zero by means of a t-test. The hormone pair
correlation that is significant across subjects is included in the
network.
Figure 3 shows the results of the analysis on the network. The
left panel shows the normal association network, and the right
panel shows the partial correlation network. Between the two
Figure 4. The triplet ACTH, TSH, and prolactin is fully connected in the network. These relation, and the relation with cortisol, are shown in
more detail. ACTH-cortisol is clearly connected. The TSH-prolactin relations is more modest but still significant. The relation ACTH-TSH is significant,
but shows a wide optimum, interestingly Cortisol-TSH shows a similarly wide optimum which is shifted to the right. ACTH-Prolactin shows a narrow
optimum while cortisol-prolactin is again wider and shifted to the right.
doi:10.1371/journal.pone.0096284.g004
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methods, the majority of links are identical though some difference
in the strength is observed. The difference between the normal and
the partial network is exemplified by the link between cortisol and
TSH, as cortisol is largely regulated by ACTH. The association
network identifies a link between cortisol and TSH, while in the
partial network the variation in cortisol (driven by ACTH) is
removed and identifies no relation between the two. A similar
observation is made between cortisol and prolactin.
3.3 Dynamic network inference
The network is based on the dynamic interactions between
hormones as described by the cross correlation function as
documented in the Appendix. To provide a better understanding
of the relations between estimated secretion sequences, some
examples are highlighted, and the intermediate steps are shown in
graphical form. In all results, the before treatment volunteer
cohort was used as the reference cohort (see above).
First, the relation between hypothalamus-pituitary-adrenal
(HPA) axis hormones ACTH and cortisol is shown. Figure 4(A)
shows the individual cross correlation profiles on the estimated
secretion profile of ACTH and cortisol. The individual results
reveal a consistent optimum at lag 1 for all individuals and some
heterogeneity in the higher lag ranges. The former translates to a
significant relation at lag 1 and the latter to non-significant average
cross correlation for higher lags. The algorithm identified the
positive and negative optima, but the correlation is significantly
different from zero in only the positive optimum. A lag of 1 means
that there is a delay of the 10 minutes in the second series
compared to the first time series, which is the interval between two
sampling points. On the other hand, a lag of 0 means that there is
no delay, while a lag of 21 means that the second series precedes
the first series.
Second, the significant relation between the two other pituitary
hormones prolactin (PRL) and TSH is shown and serves as an
example of how the network behaves in cases that are less evident.
Figure 4(B) shows the individual relation profiles based on the
estimated secretion sequences of prolactin and TSH. The results
indicate that some of the secretion events found in prolactin and
TSH are coupled, albeit to a significantly lower degree than found
for ACTH and cortisol. The negative optimum follows the positive
optimum by 30 minutes and may indicate a refractionary period (a
temporary inhibition of new events) in both hormones or in the
mechanism that drives the both secretion events. For reference,
Figure S1 shows these profiles after treatment and Figure S2 shows
these profiles for a lean cohort (BMI 21.8 kg/m2, SEM 0.4, 5 male,
4 female).
With the detailed discussion of the relations between ACTH,
cortisol, TSH, and prolactin, an attempt is made to familiarize the
reader with the application of the methodological concepts
introduced here by showing the crosscorrelation results in full
before abstracting these concepts in a network. The idea of
directionality will be illustrated here. When the crosscorrelation is
highest at lag 0 the two hormones are maximally associated
without a lag. When the highest crosscorrelation is not at lag 0, a
delay between the two hormones (may) exists. Since not all peaks
are sharp ambiguity can arise. For example, when the cross-
correlation at lag 0 and at lag 1 is similar it is not clear whether
there is a temporal direction. The directionality is here validated
by differentiating the association at the optimal lag against the
association at lag 0.
Figures 4(A) and 4(B) illustrate how the method summarizes a
relation between hormones and how the detection of optima
performs in real data. Having described the detected relations
between ACTH-cortisol and TSH-prolactin, it is only natural to
wonder whether there are detectable crossed relations between
these hormones. Figure 4(C) shows the relation between ACTH-
TSH is significant at lag 0 although the association at lag 1 is
almost as high. Figure 4(E) points out that the relation between
ACTH-prolactin is similar in timing but with some narrower
optimum. Since ACTH and cortisol are related (see Figure 4(A))
the relations with TSH on the one hand and prolactin on the other
hand are also investigated. Figure 4(D) shows that there is a
significant relation between cortisol and TSH, which is not
surprising given that ACTH and TSH are significantly associated.
The relation between cortisol and prolactin, shown in Figure 4(F),
is consistent with the latter relation. It is interesting to note that
ACTH-TSH shows an optimum at lag 0 or 1 but that cortisol-
TSH shown an optimum at lag 21 or 0, neither relations are with
detectable directionality. The relation ACTH-prolactin is sharp
and located at lag 0 while the cortisol-prolactin relation is
identified at lag 21.
The relations described in the preceding paragraph show the
interconnectedness of the hormones which is illustrative of the
network structure governing these processes. Figure 4 is the basis
for a small part of the network. The positive association between
ACTH and cortisol at lag 1 is significant in both the association
and the direction. The latter translates to a directed relation
between ACTH and cortisol in the network. The negative
association is not significant, and thus not included in the network.
All other associations are included as described before with the
addition that negative relations are shown as dashed lines to allow
Figure 5. The dynamic hormone network and the treatment
effect. Links with an arrow indicate directionality, links without are
suppressed. The black circles indicate a significant treatment effect. The
top four hormones are release in the pituitary, while the others are
released in the periphery, and glucose is ingested as food.
doi:10.1371/journal.pone.0096284.g005
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for easy visual discrimination between positively and negatively
associations. Finally, a solid black circle is added to each relation
that changed as a result of the treatment. The mathematical details
of the procedure are in the Appendix.
The network with lagged relations is shown in Figure 5. In this
figure only the non-instantaneous relations are shown for brevity,
the complete list of identified significant relations, directionality,
and treatment effects is tabulated in Table 1. Of the 36 identified
relations, 8 are significantly affected by the treatment with
bromocriptine (and 6 show a tendency to an effect with a q-value
between 0.05 and 0.10). The majority of the treatment affected
relations are targeting either TSH or PRL, but relations that target
ACTH, cortisol, insulin and GH are also found.
Discussion
The results point out the hormones that appear to be associated
during a normal day, and which of these relations changed as a
result of the treatment with dopamine d2 agonist bromocriptine.
Well-established associations were found for ACTH and cortisol
[26–29], and between cortisol and TSH [30,31]. The latter serves
as a partial validation of the method. The network further revealed
that insulin is with a positive relation to leptin, glucose and GH,
Table 1. The network is based on the data presented in this table.
Relation Lag in t Type Relation q-value p-value directionality Treatment effect q-value
GH-INS 6 2 5.432e-07 0.636 0.080,
INS-GH 15 + 5.064e-03 0.000 0.991
TSH-GH 0 + 9.897e-04 NaN 0.892
PRL-GH 0 + 5.785e-03 NaN 0.012*
GLC-GH 5 2 1.883e-03 0.252 0.366
INS-TSH 15 + 9.897e-04 0.000 0.658
INS-TSH 1 2 3.619e-04 0.091 0.573
GH-TSH 0 + 9.897e-04 NaN 0.892
GH-TSH 10 2 1.397e-03 0.000 0.080,
PRL-TSH 0 + 1.312e-03 NaN 0.592
ACTH-TSH 0 + 9.897e-04 NaN 0.185
ACTH-TSH 21 2 5.248e-05 0.000 0.043*
CRT-TSH 0 + 1.312e-03 NaN 0.080,
CRT-TSH 21 2 7.605e-04 0.000 0.051,
GLC-TSH 1 2 9.562e-03 0.303 0.146
INS-PRL 12 2 7.622e-06 0.000 0.099,
GH-PRL 0 + 5.785e-03 NaN 0.012*
TSH-PRL 0 + 1.312e-03 NaN 0.592
ACTH-PRL 0 + 4.296e-03 NaN 0.146
ACTH-PRL 23 2 3.854e-03 0.001 0.043*
CRT-PRL 23 2 5.597e-04 0.000 0.007*
GLC-PRL 21 2 1.312e-03 0.005 0.043*
INS-ACTH 6 2 1.196e-03 0.125 0.158
GH-ACTH 3 2 5.069e-03 0.151 0.040*
TSH-ACTH 0 + 9.897e-04 NaN 0.185
PRL-ACTH 0 + 4.296e-03 NaN 0.146
INS-CRT 17 2 2.510e-04 0.005 0.185
PRL-CRT 1 + 1.290e-03 0.817 0.146
ACTH-CRT 1 + 2.109e-11 0.001 0.676
GLC-CRT 2 2 2.682e-03 0.008 0.070,
INS-LPT 23 + 5.069e-03 0.040 0.687
CRT-LPT 2 2 2.878e-03 0.022 0.185
GLC-LPT 14 2 3.880e-03 0.094 0.146
INS-GLC 1 + 5.085e-03 0.744 0.862
INS-GLC 11 2 1.859e-03 0.003 0.676
GH-GLC 20 + 5.209e-03 0.013 0.291
For each relation the lag, in terms of t, is shown. The type of the relation, positive or negative, is indicated by + or 2. The q-value of the identified relations are false
discovery rate corrected (at a = 0.01). For each relation the p-value for directionality is shown (H0 : t = 0). The last column shows the q-value of the treatment effect (at
a = 0.10) and the asterisks (*) marks the significant treatment effect (,0.05), a tilde (,) a tendency to an effect (0.05,q,0.10). (t refers to a 10 minute interval).
doi:10.1371/journal.pone.0096284.t001
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and with a negative relation to ACTH, PRL and glucose. These
resuls appear inline with literature. It is worthwhile to note that the
treatment did not change the relation between insulin and PRL
(see Table 1). Similarly, a stable relation is identified between
insulin and glucose.
Contrasting the previous examples, the relation between TSH
and prolactin is only known to exist under extra-physiological
conditions in which exogenous thyrotropin-releasing hormone
(TRH) is injected in a non-physiological dose which results in an
increase in both TRH and prolactin concentration [32]. Whether
the mode of action of TRH is similar under physiological
conditions is still unknown. Here we provide evidence that can
support the hypothesis that this mechanism is also active under
physiological conditions. Based on the relations shown in Figure 4
it is speculated that the associations presented are the result of
ACTH directly, ACTH in combination with TRH, or between
CRH and TRH.
Previous observations in obese subjects have suggested that
central dopamine receptor functioning is impaired [33]. Different
studies have demonstrated that short-term treatment with
bromocriptine decreased leptin, insulin, TSH, ACTH and PRL
secretion [34]. The difference between the network before and
after bromocriptine administration might be explained by
improved insulin sensitivity. If insulin is important to feedback
signaling of different hypothalamic-pituitary hormone systems,
gastric bypass surgery in the obese patient might be a suitable
model of insulin sensitivity, because of its effect on insulin secretion
and sensitivity [35–37].
With respect to the experimental data, the largest unknown is
the day-to-day intra-subject variation. The latter issue cannot be
solved statistically, but requires repeated 24-hr observations of the
same individuals, preferably on consecutive days. Due to
restrictions on the allowable volume of blood extraction, such is
not possible without further advancement in measurement
techniques that allow for an order of magnitude reduction in the
required sample volume. The latter is notwithstanding plausible
additional (ethical) restrictions related to a .48-hr observation-
sampling regime.
The present approach of relating secretion patterns of
circulating hormones attempts to unravel known and unknown
relations between hormone systems. The results are presented
without pretending that any unknown relation, if statistically
significant, is proof of a direct relation. We have shown how
relations and differences can be detected in a case-control type of
context by assessing the treatment effect of bromocriptine. The
latter idea can be extended to other cases, and normal ranges can
be defined for well-defined subgroups. Given such a reference the
deviations in the hormone relations can interpreted as a departure
from a healthier state [38,39].
Conclusions
Detecting relations in systems with a level of complexity that is
similar to the human endocrine ensemble is not easy. Our
approach gives associations between hormones, and even in cases
of detected directionality, no claims about causation can be made.
Nevertheless with the use of observational data we are able to
detect many known relations between hormones. This serves as a
validation of the method. Most relations are previously described
in literature, but not in conjunction with the other relations. In
addition to the expected relations we were able to identify some
relations, such as TSH and PRL, that are without evidence under
physiological conditions.
What our approach adds is the unsupervised detection of these
relations in a cohort and the subsequent evalution of a treatment
effect. The network approach provides an convenient visualization
of the identified relations. The analysis of the intervention with
bromocriptine reveals that many of the relations are conserved,
pointing to a remarkable consistency in the complex relations
between endocrine entities. As the insulin resistance improved as a
result of the treatment, the relations involving TSH, cortisol and
GH appear the most affected along with the drastic changes in
relations with PRL.
Supporting Information
Materials S1 Mathematical Appendix and Figures S1
and S2. Figure S1. The after treatment relations between
ACTH, TSH, prolactin, and cortisol are shown here in
more detail. ACTH-cortisol is clearly connected. The TSH-
prolactin relation is more modest but still significant. The relation
ACTH-TSH is significant, but shows a wide optimum, interest-
ingly Cortisol-TSH shows a similarly wide optimum which is
shifted to the right. ACTH-Prolactin shows a narrow optimum
while cortisol-prolactin is again wider and shifted to the right.
Figure S2. The lean control relations between ACTH,
TSH, prolactin, and cortisol are shown here in more
detail. ACTH-cortisol is clearly connected. The TSH-prolactin
relation is more modest but still significant. The relation ACTH-
TSH is significant, but shows a wide optimum, interestingly
Cortisol-TSH shows a similarly wide optimum which is shifted to
the right. ACTH-Prolactin shows a narrow optimum while
cortisol-prolactin is again wider and shifted to the right.
(PDF)
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29. Bose M, Oliván B, Laferrére B (2009) Stress and obesity: the role of the
hypothalamic-pituitaryadrenal axis in metabolic disease. Curr Opin Endocrinol
Diabetes Obes 16: 340–346.
30. Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F (1976) The effect
of glucocorticoid administration on human pituitary secretion of thyrotropin and
prolactin. J Clin Endocrinol Metab 43: 338–346.
31. Roelfsema F, Pereira AM, Biermasz NR, Frolich M, Keenan DM, et al. (2009)
Diminished and irregular tsh secretion with delayed acrophase in patients with
cushing’s syndrome. Eur J Endocrinol 161: 695–703.
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